Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.

[1]  T. Ishizawa,et al.  Repeat Hepatectomy for Early Recurrence of Colorectal Liver Metastases—Prognostic Impacts Assessed from the Recurrence Pattern , 2019, World Journal of Surgery.

[2]  W. Jarnagin,et al.  Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy , 2019, World Journal of Surgery.

[3]  D. Berger,et al.  The impact of postoperative morbidity on survival in patients with metastatic colon and rectal cancer , 2019, Journal of surgical oncology.

[4]  A. Sugioka,et al.  Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancer—a retrospective observational study , 2019, World Journal of Surgical Oncology.

[5]  Andrew J. Lee,et al.  Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases , 2018, Annals of Surgical Oncology.

[6]  G. Poston,et al.  Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  N. Demartines,et al.  Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations , 2016, World Journal of Surgery.

[8]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  T. Ishizawa,et al.  Parenchymal-Sparing Hepatectomy Does Not Increase Intrahepatic Recurrence in Patients with Advanced Colorectal Liver Metastases , 2016, Annals of Surgical Oncology.

[10]  J. Vauthey,et al.  RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases , 2016, Annals of Surgical Oncology.

[11]  J. Vauthey,et al.  Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival. , 2016, Annals of surgery.

[12]  F. Giuliante,et al.  Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients , 2014, Annals of Surgical Oncology.

[13]  J. Shindoh,et al.  Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival , 2013, The British journal of surgery.

[14]  Steven A. Curley,et al.  RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases , 2013, Annals of surgery.

[15]  S. Curley,et al.  Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy , 2013, Annals of surgery.

[16]  J. Shindoh,et al.  Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases , 2012, Annals of surgery.

[17]  D. Collins,et al.  Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. , 2012, The British journal of radiology.

[18]  H. Schlitt,et al.  Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings , 2012, Annals of surgery.

[19]  M. Gonen,et al.  Hepatic Pedicle Clamping During Hepatic Resection for Colorectal Liver Metastases: No Impact on Survival or Hepatic Recurrence , 2012, Annals of Surgical Oncology.

[20]  S. Curley,et al.  Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[21]  T. Hickish,et al.  A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  S. Curley,et al.  High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  I. Endo,et al.  Impact of Postoperative Morbidity on Long-Term Survival After Resection for Colorectal Liver Metastases , 2016, Annals of Surgical Oncology.

[24]  D. Sargent,et al.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M. Makuuchi,et al.  Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .

[26]  R. Adam,et al.  R1 Resection by Necessity for Colorectal Liver Metastases: Is It Still a Contraindication to Surgery? , 2008, Annals of surgery.

[27]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[28]  E. Abdalla,et al.  Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome , 2007, The British journal of surgery.

[29]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Gonen,et al.  The Impact of Margins on Outcome After Hepatic Resection for Colorectal Metastasis , 2007, Annals of surgery.

[31]  J. Figueras,et al.  Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  Ronald P. DeMatteo,et al.  Anatomie segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases , 2000, Journal of Gastrointestinal Surgery.

[33]  S. Strasberg,et al.  Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. , 2005, Journal of hepato-biliary-pancreatic surgery.

[34]  Evelyne M. Loyer,et al.  Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases , 2005, Annals of surgery.

[35]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.